NCT00724542Unknown不适用
Evaluation of Lifestyle and Therapeutic Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease.
Ministry of Science and Technology of the People´s Republic of China1 个研究点 分布在 1 个国家目标入组 1,600 人开始时间: 2008年7月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 1,600
- 试验地点
- 1
- 主要终点
- TypeⅡDiabetes Mellitus
研究概览
简要总结
The purpose of this study is to determine whether therapeutic intervention on impaired glucose tolerance in patients with coronary heart disease can decrease the incidence of new onset DM.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 40 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with coronary heart disease
- •Impaired Glucose Tolerance
排除标准
- •Age < 40yr or > 75yr
- •Diabetes Mellitus
- •Scr > 2.0 mg/dL（176 μmol/L）
- •ALT or AST > 2.5 ULN
- •Hb < 90g/L
- •Heart Failure
- •Infection
- •Undergo other interventional clinical trial
研究组 & 干预措施
Drug
Experimental
Voglibose tablets with lifestyle intervention
干预措施: Voglibose tablets (Drug)
结局指标
主要结局
TypeⅡDiabetes Mellitus
时间窗: 2 years
次要结局
- Occurrence of Cardiovascular Events(2 years)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Lifestyle Intervention for Treatment of DiabetesType 2 DiabetesOverweightObesityNCT01806727Wake Forest University260
已完成
4 期
Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)Metabolic SyndromeHypertensionNCT00234858Abbott280
招募中
不适用
Lifestyle Patterns and Glycemic ControlPre-diabetesNCT05224986Columbia University34
Unknown
不适用
Lifestyle Intervention Treatment for Patients With Mild Obstructive Sleep ApneaObstructive Sleep ApneaNCT00486746Kuopio University Hospital81
已完成
2 期
Lifestyle Intervention to Improve Insulin Sensitivity and Markers of Cardiovascular Risk in Prostate Cancer SurvivorsProstate CancerNCT00738140Massachusetts General Hospital15